We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

i-Sens

Develops and manufactures self monitoring blood glucose test systems, including POCT diagnostic devices such as blood... read more Featured Products: More products

Download Mobile App





i-SENS Highlights Connected Diagnostic Systems at MEDICA 2025

By LabMedica International staff writers
Posted on 17 Nov 2025

i-SENS is presenting its latest in vitro diagnostic innovations at MEDICA 2025, highlighting connected testing platforms for clinical and near-patient applications. More...

In Hall 3, Booth B51, i-SENS is showcasing its i‑SmartCare 10 and i‑Smart 30 Pro systems alongside additional point‑of‑care (POC) analyzers intended to provide precise, efficient testing across hospital laboratories and near‑patient workflows. 

The i-SmartCare 10 is a blood gas, electrolyte, and metabolites analyzer optimized for POC use. The compact and lightweight analyzer features a high-capacity battery that supports two hours of mobile, continuous testing, plus an easy-to-manage all-in-one cartridge system. The i-Smart 30 Pro is an electrolyte analyzer that measures Na+, K+, and CI- concentrations, reporting results in 35 seconds on a color screen. Added benefits include an all-in-one cartridge that can be used for four weeks, battery power for two hours, and fast and error-free data entry using a barcode scanner.

The company will also feature the CareSens Air Continuous Glucose Monitoring System (CGMS). CareSens Air CGM is a 15-day, all-in-one sensor that provides real-time glucose monitoring, with data easily accessible through the CareSens app. The sensor is just 5 mm thick and weighs only 4.5 g.. Also on display at the i-SENS booth is a wide variety of CareSens Blood Glucose Monitoring System (BGMS) models, designed for accuracy, ease of use, and reliability in diverse care environments.

i-SENS’s participation at MEDICA 2025 underscores the company’s commitment to advancing smart, connected diagnostics that enhance clinical decision-making and improve patient outcomes. By continuously developing innovative and accessible solutions, i-SENS strives to support healthcare professionals and contribute to a more connected, data-driven future of care.

Related Links:
i-SENS


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.